TTrialPathMatch Me to Trials
← Back to trials
RecruitingParkinson Disease

Light Therapy Intervention in Individuals With Parkinson's Disease

Eligible age

50–80 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The study looks to investigate the effects that light therapy delivered to the frontal cortex could have on Parkinson's disease related symptoms ( both cognitive and motor). The therapy is a non invasive technique that deliverers low level wavelength light to the front part of the head for 12 minutes. for this study the therapy will be done 3 times a week for 6 weeks. To measure the potential effects on the therapy in Parkinson symptoms, we will do a set of cognitive and motor test before and after the intervention to measure any changes as well as control for any potential markers such as age, sex, disease level, medication and exercise.

Sponsor: University of Delaware

You may qualify if…

  • ✓ Diagnosis of Parkinson disease

You may not qualify if…

  • ✕ 1. Participants who are unable to comply with study visit/testing requirements (e.g.
  • ✕ participants who cannot go off PD medication for the pre-, post-, and 3-month assessments).
  • ✕ 2. Participants who are unable to provide consent.
  • ✕ 3. Participants with a Deep Brain Stimulation (DBS) device.
  • ✕ 4. Participants who have a history of a psychiatric disorder
  • ✕ 5. Participants with PD who have other concurrent movement/neurological conditions, including dystonia, dementia, epilepsy etc.
  • ✕ 6. Participants with a clinical diagnosis of PD that is not considered primary (e.g.
  • ✕ vascular parkinsonism) or participants where an atypical form of parkinsonism is suspected (e.g., progressive supranuclear palsy, multiple system atrophy).

Where it's recruiting

Delaware

Newark

Source: ClinicalTrials.gov · NCT06916260 · last updated 2025-04-08

Light Therapy Intervention in Individuals With Parkinson's Disease · TrialPath